IFCC & EFLM

New EFLM webinar: old and novel bone markers as a routine biochemical marker

By Dmitrii

Posted on December 13, 2021

EFLM E-LEARNING

a selection of interactive, web-based, educational resources designed by EFLM experts to improve your daily practice

Darko Cerne, Chair of the EFLM WG Distance Education and e-Learning,
informs on next scheduled webinar and reminds that
the free access to EFLM webinars is reserved to EFLM Academy Members
(in order with the annual fee 2021)

Click here to know more about the EFLM Academy.

EFLM WEBINAR

Why we are not using old and novel bone markers as a routine biochemical marker?

21 December 2021

at h. 18.00 CET (duration 1 h)

Speaker: Sepici Dincel Aylin (TR)
Moderator: Meltem Sengelen (TR, UK)

Cilck here to register

Bone is a mineralized collagen matrix together with embedded bone cells. It’s remodeling is characterized by temporal and spatial coupling of bone formation and resorption. Bone turnover markers (BTMs) are useful in assessing bone remodelling at the cellular level. Until the harmonization is achieved, the measurement of one formation marker and one resorption marker by standardized assays has been recommended to predict bone loss, estimate fracture risk and the response to osteoporosis treatments by assessing bone turnover in recents reports of working groups.
Nowadays there has been a new approach which bases on our understanding of bone metabolism that is related to new markers. Furthermore the clinical use of those biochemical markers has not been fully established.
In conclusion, to address the limitations of variability of BTM, the working groups are implementing different complimentary activities around the harmonization and the use of BTMs. The relevant biochemical markers are still lacking in the clinical guidelines; none of the bone biomarkers considered to be an ideal marker.

Key Learning Objectives

– to review the life cycle of bone and related bone turnover markers

– to recognise the clinical and biochemical features of bone turnover markers

– to be able to discuss preanalytical / analytical problems and discrepancies

– to describe the diagnostic, prognostic usefulness of bone turnover markers

ABOUT THE SPEAKER

Aylin Sepici Dincel
Department of Medical Biochemistry, Faculty of Medicine, Gazi University, Turkey

Aylin Sepici Dinçel, MD, PhD is Professor of Biochemistry. She has been working at Gazi University Faculty of Medicine since 2005 and an executive board member of the Turkish Biochemical Society since 2015. She is the head of the Body Fluids Working Group of Turkish Biochemical Society, vice editor of Turkish Journal of Biochemistry, Turkish Ambassador of FEBS Education Committee, corresponding member of the IFCC Congresses and Conferences Committee and IFCC Committee on Bone Metabolism. Her main research interests include bone markers in hip fracture and bone healing mechanisms, risk assessment tools by biochemical markers and both graduate and undergraduate biochemistry laboratory education.

European Federation of Clinical Chemistry and Laboratory Medicine

Egmontstraat 11, Brussels
Belgium

ACCLMU

New EFLM webinar: old and novel bone markers as a routine biochemical marker

ABOUT THE SPEAKER

Leave a Reply

Most Popular

Invitations to participate in a joint Congress and EFLM UEMS 21-24 September 2016 in Warsaw

Textbook “Clinical Biochemistry” 2013 Section 1

Proposal for publication of abstracts

Scientific & Practical Conference “Actual Issues of Laboratory Medicine”

Features of quality control of laboratory tests using test systems made by CJSC Vector-Best

Plenary lecture on June 21, 2015, at the IFCC Conference in Paris

Presentations at the Scientific & practical conference with international participation “DSTU EN ISO 15189:2015 – Roadmap to Quality of Laboratory Tests” (19-20 October 2016)

IFCC membership survey

The concept of implementation of ISO EN ISO 15189 into the practice of medical laboratories of Ukraine

Participation of the Association representatives in the IFCC General Conference